Bone Marrow Flow Cytometry in Staging of Patients With B-cell Non-Hodgkin Lymphoma

논문상세정보
' Bone Marrow Flow Cytometry in Staging of Patients With B-cell Non-Hodgkin Lymphoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • bonemarrow
  • flow cytometry
  • immunophenotyping
  • non-hodgkin lymphoma
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,684 0

0.0%

' Bone Marrow Flow Cytometry in Staging of Patients With B-cell Non-Hodgkin Lymphoma' 의 참고문헌

  • Value of bilateral bone marrow biopsy specimens in non-Hodgkin’s lymphoma
    Juneja SK J Clin Pathol 43 : 630 ~ 632 [1990]
  • Value of bilateral bone marrow biopsy specimens in non-Hodgkin’s lymphoma
    Juneja SK J Clin Pathol 43 630-632 [1990]
  • Usefulness of flow cytometrici mmunophenotyping for bone marrow staging in patients with mantle cell lymphoma after therapy
    Liu W Am J Clin Pathol 137 : 634 ~ 640 [2012]
  • Usefulness of flow cytometrici mmunophenotyping for bone marrow staging in patients with mantle cell lymphoma after therapy
    Liu W Am J Clin Pathol 137 634-640 [2012]
  • Use of molecular diagnostic methods for lymphoma staging in bilateral bone marrow biopsies
    Murphy TD Mol Diagn 2 : 177 ~ 182 [1997]
  • Use of molecular diagnostic methods for lymphoma staging in bilateral bone marrow biopsies
    Murphy TD Mol Diagn 2 177-182 [1997]
  • Ten antibodies, six colors, twelve parameters: a multiparameter flow cytometric approach to evaluate leptomeningeal disease in B-cell non-Hodgkin’s lymphomas
    Stacchini A Cytometry B Clin Cytom 82 : 139 ~ 144 [2012]
  • Ten antibodies, six colors, twelve parameters: a multiparameter flow cytometric approach to evaluate leptomeningeal disease in B-cell non-Hodgkin’s lymphomas
    Stacchini A Cytometry B Clin Cytom 82 139-144 [2012]
  • Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy
    Jennings CD Blood 90 : 2863 ~ 2892 [1997]
  • Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy
    Jennings CD Blood 90 2863-2892 [1997]
  • Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d’Etudes des Lymphomes Agressifs
    Coiffier B J Clin Oncol 9 : 211 ~ 219 [1991]
  • Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d’Etudes des Lymphomes Agressifs
    Coiffier B J Clin Oncol 9 211-219 [1991]
  • Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients
    Morice WG Mayo Clin Proc 83 : 776 ~ 785 [2008]
  • Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients
    Morice WG Mayo Clin Proc 83 776-785 [2008]
  • Is the International Prognostic Index for Aggressive Lymphoma patients useful for follicular lymphoma patients?
    Bastion Y J Clin Oncol 12 : 1340 ~ 1342 [1994]
  • Is the International Prognostic Index for Aggressive Lymphoma patients useful for follicular lymphoma patients?
    Bastion Y J Clin Oncol 12 1340-1342 [1994]
  • Immunophenotypic evaluation of the bone marrow in non-Hodgkin’s lymphoma
    Fineberg S Hum Pathol 24 : 636 ~ 642 [1993]
  • Immunophenotypic evaluation of the bone marrow in non-Hodgkin’s lymphoma
    Fineberg S Hum Pathol 24 636-642 [1993]
  • Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma
    Hanson CA Blood 94 : 3889 ~ 3896 [1999]
  • Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma
    Hanson CA Blood 94 3889-3896 [1999]
  • ICSH guidelines for the standardization of bone marrow specimens and reports
    Lee SH Int J Lab Hematol 30 : 349 ~ 364 [2008]
  • ICSH guidelines for the standardization of bone marrow specimens and reports
    Lee SH Int J Lab Hematol 30 349-364 [2008]
  • High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin’s lymphoma: a dose-finding pilot study
    Shipp MA J Clin Oncol 13 : 2916 ~ 2923 [1995]
  • High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin’s lymphoma: a dose-finding pilot study
    Shipp MA J Clin Oncol 13 2916-2923 [1995]
  • Follicular lymphoma in staging bone marrow specimens: correlation of histologic findings with the results of flow cytometry immunophenotypic analysis
    Iancu D Arch Pathol Lab Med 131 : 282 ~ 287 [2007]
  • Follicular lymphoma in staging bone marrow specimens: correlation of histologic findings with the results of flow cytometry immunophenotypic analysis
    Iancu D Arch Pathol Lab Med 131 282-287 [2007]
  • Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas
    Palacio C Haematologica 86 : 934 ~ 940 [2001]
  • Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas
    Palacio C Haematologica 86 934-940 [2001]
  • Diagnosis and classification of B-cell non-Hodgkin lymphomas. The role of multiparameter flow cytometry
    Carulli G Clin Ter 163 : 47 ~ 57 [2012]
  • Diagnosis and classification of B-cell non-Hodgkin lymphomas. The role of multiparameter flow cytometry
    Carulli G Clin Ter 163 47-57 [2012]
  • Detection of genetic translocations in lymphoma using fluorescence in situ hybridization
    Reichard KK Methods Mol Biol 999 : 189 ~ 202 [2013]
  • Detection of genetic translocations in lymphoma using fluorescence in situ hybridization
    Reichard KK Methods Mol Biol 999 189-202 [2013]
  • Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma(DLBCL)
    Nedomova R Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 157 : 239 ~ 247 [2013]
  • Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma(DLBCL)
    Nedomova R Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 157 239-247 [2013]
  • Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas
    Coad JE Am J Surg Pathol 21 : 1047 ~ 1056 [1997]
  • Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas
    Coad JE Am J Surg Pathol 21 1047-1056 [1997]
  • Comparative utility of diagnostic bone-marrow components: a 10-year study
    Barekman CL Am J Hematol 56 : 37 ~ 41 [1997]
  • Comparative utility of diagnostic bone-marrow components: a 10-year study
    Barekman CL Am J Hematol 56 37-41 [1997]
  • Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms
    Dunphy CH Am J Clin Pathol 109 : 625 ~ 630 [1998]
  • Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms
    Dunphy CH Am J Clin Pathol 109 625-630 [1998]
  • Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL)
    Perea G Histopathology 45 : 268 ~ 274 [2004]
  • Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL)
    Perea G Histopathology 45 268-274 [2004]
  • Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology
    Duggan PR Cancer 88 : 894 ~ 899 [2000]
  • Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology
    Duggan PR Cancer 88 894-899 [2000]
  • Bone marrow staging in patients with non-Hodgkin’s lymphoma: is flow cytometry a useful test?
    Naughton MJ Cancer 82 : 1154 ~ 1159 [1998]
  • Bone marrow staging in patients with non-Hodgkin’s lymphoma: is flow cytometry a useful test?
    Naughton MJ Cancer 82 1154-1159 [1998]
  • Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia
    Winfield DA J Clin Pathol 45 : 855 ~ 859 [1992]
  • Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia
    Winfield DA J Clin Pathol 45 855-859 [1992]
  • Assessment of bone marrow involvement in non-Hodgkin’s lymphomas: comparison between histology and flow cytometry
    Merli M Eur J Haematol 85 : 405 ~ 415 [2010]
  • Assessment of bone marrow involvement in non-Hodgkin’s lymphomas: comparison between histology and flow cytometry
    Merli M Eur J Haematol 85 405-415 [2010]
  • Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin’s lymphomas: long-term results for 96 patients with tumors > 5 cm
    Munck JN Ann Oncol 7 : 925 ~ 931 [1996]
  • Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin’s lymphomas: long-term results for 96 patients with tumors > 5 cm
    Munck JN Ann Oncol 7 925-931 [1996]
  • A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project
    N Engl J Med 329 : 987 ~ 994 [1993]
  • A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project
    N Engl J Med 329 987-994 [1993]